Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade B 24.58 4.24% 1.00
FLXN closed up 4.24 percent on Wednesday, February 21, 2018, on 1.54 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
6 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical FLXN trend table...

Date Alert Name Type % Chg
Feb 21 Crossed Above 50 DMA Bullish 0.00%
Feb 21 Wide Bands Range Expansion 0.00%
Feb 21 Overbought Stochastic Strength 0.00%
Feb 21 Upper Bollinger Band Touch Strength 0.00%
Feb 20 50 DMA Resistance Bearish 4.24%
Feb 20 Wide Bands Range Expansion 4.24%
Feb 16 Fell Below 50 DMA Bearish 5.99%
Feb 16 Wide Bands Range Expansion 5.99%
Feb 15 Crossed Above 50 DMA Bullish 0.00%
Feb 15 Stochastic Reached Overbought Strength 0.00%

Older signals for FLXN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.25
52 Week Low 16.51
Average Volume 812,937
200-Day Moving Average 22.9237
50-Day Moving Average 24.3152
20-Day Moving Average 23.2565
10-Day Moving Average 23.488
Average True Range 1.3992
ADX 19.51
+DI 17.0
-DI 19.91
Chandelier Exit (Long, 3 ATRs ) 21.2024
Chandelier Exit (Short, 3 ATRs ) 24.8776
Upper Bollinger Band 24.9279
Lower Bollinger Band 21.5851
Percent B (%b) 0.9
BandWidth 14.373616
MACD Line -0.0641
MACD Signal Line -0.287
MACD Histogram 0.2229
Fundamentals Value
Market Cap 784.23 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -7.90
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.28
Resistance 3 (R3) 27.25 26.33 26.83
Resistance 2 (R2) 26.33 25.64 26.34 26.68
Resistance 1 (R1) 25.45 25.21 25.89 25.48 26.53
Pivot Point 24.53 24.53 24.75 24.54 24.53
Support 1 (S1) 23.65 23.84 24.09 23.68 22.63
Support 2 (S2) 22.73 23.41 22.74 22.48
Support 3 (S3) 21.85 22.73 22.33
Support 4 (S4) 21.88